These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32229324)

  • 1. Neurocognitive processes in d-cycloserine augmented single-session exposure therapy for anxiety: A randomized placebo-controlled trial.
    Reinecke A; Nickless A; Browning M; Harmer CJ
    Behav Res Ther; 2020 Jun; 129():103607. PubMed ID: 32229324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
    Pyrkosch L; Mumm J; Alt I; Fehm L; Fydrich T; Plag J; Ströhle A
    J Psychiatr Res; 2018 Oct; 105():153-163. PubMed ID: 30237105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficult-to-treat pediatric obsessive-compulsive disorder: feasibility and preliminary results of a randomized pilot trial of D-cycloserine-augmented behavior therapy.
    Farrell LJ; Waters AM; Boschen MJ; Hattingh L; McConnell H; Milliner EL; Collings N; Zimmer-Gembeck M; Shelton D; Ollendick TH; Testa C; Storch EA
    Depress Anxiety; 2013 Aug; 30(8):723-31. PubMed ID: 23722990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
    Scheeringa MS; Weems CF
    J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
    Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
    Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.
    Hofmeijer-Sevink MK; Duits P; Rijkeboer MM; Hoogendoorn AW; van Megen HJ; Vulink NC; Denys DA; van den Hout MA; van Balkom AJ; Cath DC
    J Clin Psychopharmacol; 2017 Oct; 37(5):531-539. PubMed ID: 28820746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early effects of exposure-based cognitive behaviour therapy on the neural correlates of anxiety.
    Reinecke A; Thilo KV; Croft A; Harmer CJ
    Transl Psychiatry; 2018 Oct; 8(1):225. PubMed ID: 30341276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder.
    Otto MW; Tolin DF; Simon NM; Pearlson GD; Basden S; Meunier SA; Hofmann SG; Eisenmenger K; Krystal JH; Pollack MH
    Biol Psychiatry; 2010 Feb; 67(4):365-70. PubMed ID: 19811776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
    de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
    Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Augmentation of Cognitive Behavior Therapy With Weight-Adjusted d-Cycloserine vs Placebo in Pediatric Obsessive-Compulsive Disorder: A Randomized Clinical Trial.
    Storch EA; Wilhelm S; Sprich S; Henin A; Micco J; Small BJ; McGuire J; Mutch PJ; Lewin AB; Murphy TK; Geller DA
    JAMA Psychiatry; 2016 Aug; 73(8):779-88. PubMed ID: 27367832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-cycloserine enhancement of exposure therapy for social anxiety disorder depends on the success of exposure sessions.
    Smits JA; Rosenfield D; Otto MW; Marques L; Davis ML; Meuret AE; Simon NM; Pollack MH; Hofmann SG
    J Psychiatr Res; 2013 Oct; 47(10):1455-61. PubMed ID: 23870811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.
    Hofmann SG; Smits JA; Rosenfield D; Simon N; Otto MW; Meuret AE; Marques L; Fang A; Tart C; Pollack MH
    Am J Psychiatry; 2013 Jul; 170(7):751-8. PubMed ID: 23599046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
    Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
    Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
    Smits JAJ; Pollack MH; Rosenfield D; Otto MW; Dowd S; Carpenter J; Dutcher CD; Lewis EM; Witcraft SM; Papini S; Curtiss J; Andrews L; Kind S; Conroy K; Hofmann SG
    JAMA Netw Open; 2020 Jun; 3(6):e206777. PubMed ID: 32496566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial.
    Andersson E; Hedman E; Enander J; Radu Djurfeldt D; Ljótsson B; Cervenka S; Isung J; Svanborg C; Mataix-Cols D; Kaldo V; Andersson G; Lindefors N; Rück C
    JAMA Psychiatry; 2015 Jul; 72(7):659-67. PubMed ID: 25970252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-cycloserine-augmented one-session treatment of specific phobias in children and adolescents.
    Farrell LJ; Waters AM; Oar EL; Tiralongo E; Garbharran V; Alston-Knox C; McConnell H; Collings N; Zimmer-Gembeck M; Donovan CL; Testa C; Storch EA; Ollendick TH
    Brain Behav; 2018 Jun; 8(6):e00984. PubMed ID: 30106248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive-behavioural therapy with post-session D-cycloserine augmentation for paediatric obsessive-compulsive disorder: pilot randomised controlled trial.
    Mataix-Cols D; Turner C; Monzani B; Isomura K; Murphy C; Krebs G; Heyman I
    Br J Psychiatry; 2014 Jan; 204(1):77-8. PubMed ID: 24262813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose timing of D-cycloserine to augment cognitive behavioral therapy for social anxiety: Study design and rationale.
    Hofmann SG; Carpenter JK; Otto MW; Rosenfield D; Smits JA; Pollack MH
    Contemp Clin Trials; 2015 Jul; 43():223-30. PubMed ID: 26111923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-Cycloserine facilitation of exposure therapy improves weight regain in patients with anorexia nervosa: a pilot randomized controlled trial.
    Levinson CA; Rodebaugh TL; Fewell L; Kass AE; Riley EN; Stark L; McCallum K; Lenze EJ
    J Clin Psychiatry; 2015 Jun; 76(6):e787-93. PubMed ID: 26132687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining D-cycloserine with appetitive extinction learning modulates amygdala activity during recall.
    Ebrahimi C; Koch SP; Friedel E; Crespo I; Fydrich T; Ströhle A; Heinz A; Schlagenhauf F
    Neurobiol Learn Mem; 2017 Jul; 142(Pt B):209-217. PubMed ID: 28512009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.